Health Professional Radio - Podcast

Saad Harti, founder and CEO of Swiss-based biotech Legacy Healthcare discusses the company's positive Phase 2/3 data and filing of their lead prescription botanical drug Coacillium for the treatment of an autoimmune condition, alopecia areata. He also talks about a recent survey which found that patients would prefer prescription botanical drugs to treat their chronic diseases. #​LegacyHealthc...

Dr. Jay Backstrom, MD, MPH, President and CEO, and Ted Myles, COO and CFO of Scholar Rock , a Phase 3 clinical-stage biopharmaceutical company, discusses new TOPAZ 36-month apitegromab extension data reinforcing long-term substantial and sustained improvement of motor function in patients with nonambulatory spinal muscular atrophy (SMA). #SMA #raredisease #spinalmuscularatrophy Dr. Jay Backstrom j...

Dr. Reid Merryman, MD, an attending physician in the Lymphoma Program at the Dana-Farber Cancer Institute discusses Genmab and AbbVie's preliminary data from its ongoing phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in patients across B-Cell lymphomas that were presented at the European Hematology Association's (EHA) Annual Meeting 2023.   Read the abstract here . #EPCORE Dr. Mer...

Nationally known ophthalmologist, Dr. Neda Shamie, partner of the Maloney-Shamie Vision Institute in Los Angeles, discusses the signs, symptoms, and treatment options for cataracts, as well as the findings from Alcon's global "Alcon Eye On Cataract Survey." Please visit mycataracts.com for more information. #Alcon #Cataracts #Cataractsurgery Dr. Neda Shamie is a cataract, LASIK and c...

Minaa B ., a licensed mental health professional discusses her new book "Owning Our Struggles" an important book advocating for mental health inclusivity. She talks about how community-care is as important as self-care, cultural healing practices, building healthy relationships, holding yourself accountable, and healing parent-child relationships. #MentalHealth Minaa B. is a writer, auth...

Returning guest, Allison London Brown, CEO of LUMINELLE discusses LUMINELLE SUSTAINE endoscopic system and the recently FDA-cleared LUMINELLE Bx (Biopsy) RotoSheath of which she is a co-inventor. She talks about the uptick in the number of women diagnosed with uterine cancers due to the pandemic lockdown and certain procedures being considered elective. She shares her thoughts on the need for uter...

Dr. Matthew Old, MD, Director of the Department of Otolaryngology–Head and Neck Surgery at The James, Ohio State University, Comprehensive Cancer Center discusses HPV-related cancer, cancer treatment/detection, and why vaccination is important for older adults. #ThroatCancer I am a professor and director of the Department of Otolaryngology – Head and Neck Surgery. I was named to the Castle Connoll...

Dr. Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center and principal investigator of the study discusses the updated efficacy and safety data results for Seagen’s ADCETRIS ® (brentuximab vedotin) in combination with an immunotherapy-containing regimen. These data were presented at the 17th Internatio...

Rae Jimenez, Chief Product Officer at AAPC discusses medical coding and why it's important for patients to know “what's the code" prior to getting a surgery or procedure and how nurses and doctors can better advise their patients. Medical coding has also become a great career for many people allowing some to work from home. #aapc #revenuecycle #medicalcoding Rae has over 30 years’ exp...

KimberLee Heidmann, Executive Vice President of Patient Experience and Customer Success at Scout Clinical , part of the Meeting Protocol Worldwide family, discusses Scout Clinical's mission to help patients stay enrolled in clinical trials. On average, clinical trial participants must travel over 60 miles one way to visit clinical trial sites, contributing to just over half of all trials being...

Returning guest, Sylvie Beljanski, Founder and Executive Vice President of the Beljanski Foundation and a renowned expert in the field of natural approaches to cancer, discusses the foundation's latest research project on breast cancer stem cells. To learn more visit https://integrativecancerconference.com/ # BeljanskiFoundation Sylvie Beljanski, a French lawyer by trade, is a health advocate...

Drs. Silvia Morris, MD, Diane Boykin, MD, and Angela Walker, MD, discuss their new book “The Game Plan: A Woman’s Guide to Becoming a Doctor and Living a Life in Medicine.” They talk about medical career pathways, why more female doctors are needed in the profession, and share about their own careers. #TheGamePlan Dr. Sylvia E. Morris hails from Los Angeles. She completed her bachelor of arts at t...

Dr. David Neubauer, MD, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine discusses the current landscape of insomnia treatments and the petition for the DEA to de-schedule the Dual Orexin Receptor Antagonists (DORAs) class of insomnia medications which offer an entirely different approach to treating insomnia and meets an unmet need for longer-term use with littl...

Mei Mei Hu, CEO of Vaxxinity , discusses the company's approach to targeting a wide variety of chronic diseases such as Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia, as well as their COVID-19 booster vaccine. Vaxxinity aims to utilize its unique synthetic peptide platform technology to bring the convenience, efficiency, and cost-effectiveness of vaccines to the treatment and pr...

Dr. Emri Seli, March of Dimes Chief Scientific Officer and Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine discusses the March of Dimes ' increased focus on recurrent pregnancy loss (RPL) and the work March of Dimes researchers will perform to gather new insights into RPL through the lens of environmental factors. #marchofdimes Dr. Emre Seli, March of...

Dr. Nicholas Robert, CMO of Ontada , discusses new research that examines potential factors that may impact care and outcomes for affected communities with a common and aggressive form of cancer, Triple Negative Breast Cancer. ​​#rwd #sdoh #rwe In his role as Chief Medical Officer, Dr. Robert is responsible for deepening Ontada’s clinical focus and expertise. As the senior clinical leader at Ontad...

Dr. Ron Silverman, MD, Senior Vice President, Global Medical and Clinical Affairs and Chief Medical Officer at 3M discusses how the company’s AI and automation technology has helped healthcare providers increase efficiency and focus more on patient care. To reduce physician burnout and streamline processes, 3M has developed software and services to help identify, prioritize, and address documentat...

Returning guest, Dr. Michael Irizarry, Senior Vice President and Deputy Chief Clinical Officer, Alzheimer's Disease and Brain Health, at Eisai Inc. discusses the U.S. Food and Drug Administration’s (FDA) traditional approval of LEQEMBI ® (lecanemab-irmb) 100 mg/mL injection for intravenous use as the first and only disease-modifying treatment for Alzheimer’s disease (AD). #LEQEMBI Dr. Irizarry...

Dr. Laura Korb Ferris, MD, PhD, Professor, University of Pittsburgh Clinical and Translational Science Institute and Director of Clinical Trials, UPMC Department of Dermatology discusses the new phase 2b FRONTIER 1 study data that demonstrates the potential of JNJ-2113 , the novel first and only oral IL-23 antagonist peptide to “potentially change the treatment paradigm” for patients with moderate...

Ali Carbone, sister to three brothers with autism, discusses her new memoir called “ What Are You Looking At? ” Ali shares her firsthand perspective and gives light to the untold stories of siblings with intellectual and developmental disabilities (IDD). #DisabilityAdvocate  #WAYLA #CitizensOptionsUnlimited On April 3rd, sister-advocate Ali Carbone published her first memoir titled What Are You Lo...

Returning guest, Dr. Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show TAGRISSO ® (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), with 88% of patients alive at five years compared to placebo in the adjuvant treatment of patients...

Mark Stadler, CEO of AccessHope discusses cancer care and why access to the best cancer facilities is out of reach for the majority of Americans, particularly those impacted by social determinants of health (SDOH). He talks about bridging the gap in cancer treatment disparities, empowering community oncologists and how employers can support employees with cancer beyond the initial diagnosis and th...

Board-Certified Dermatologist, Dr. Melinda Greenfield discusses plaque psoriasis and how moderate-to-severe plaque psoriasis patients can make the most of warm weather.   She talks about treatment options, some things her patients  have found helpful in managing their symptoms, and what a patient struggling with moderate-to-severe plaque psoriasis  should do. For more information visit www.ilumya....

Dr. Ahsan Arozullah, MD, MPH,  Senior Vice President, Head of Oncology Development at Astellas discusses the company's presence at the 2023  American Society of Clinical Oncology (ASCO) Annual Meeting.   He talks about the expanding  portfolio of approved and investigational cancer therapies and how  the research underscores the company’s focus on pursuing targeted therapies for hard-to-treat...

Sean Gilligan, Chief Operating Officer at AVS , an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease discusses his years of experience in the medical device field and how it has evolved and talks about hospitals evaluating their tech investments in a tight economy. #AVS Sean Gilligan is the Chief Operations Officer of AVS Pulse. Befor...